Stay updated on Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has updated the intervention details and contact information, including the addition of a verified status and a new revision version, while removing previous entries for the type of intervention and principal investigators.
    Difference
    5%
    Check dated 2025-01-12T17:05:15.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.0%
    Check dated 2024-12-14T12:22:29.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information on who can answer questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.
    Difference
    2%
    Check dated 2024-12-07T10:39:59.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.
    Difference
    2%
    Check dated 2024-11-23T04:27:15.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Several key health-related websites, including MedlinePlus and DailyMed, have been removed from the monitored list, indicating a potential shift in focus or resource availability.
    Difference
    0.2%
    Check dated 2024-11-15T23:01:29.000Z thumbnail image
  9. Check
    72 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding several new resources related to skin cancer and treatments like Cetuximab and Pembrolizumab, while removing the previous version 2.12.1.
    Difference
    3%
    Check dated 2024-11-08T18:06:26.000Z thumbnail image

Stay in the know with updates to Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.